MMJ PhytoTech Ltd (ASX:MMJ) Half Yearly Report
MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its review of operations for the half-year period ended 31 December 2017.
Companies in the News
Drugs & OTC
MMJ PhytoTech Ltd (ASX:MMJ) Investor Presentation
MMJ PhytoTech Limited (ASX:MMJ) is pleased to attach an investor presentation and speaker notes to be presented by the Company's Chief Executive Officer Jason Conroy today in Sydney at the Finance News Network Investor Event.
Queensland Bauxite Ltd (ASX:QBL) A World First for MCL in Autoimmune Disease Research
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that its subsidiary company Medical Cannabis Limited through its wholly owned subsidiary Medical Cannabis Research Group Pty Ltd, has signed a Research Funding Agreement with the Research & Development Foundation at the Technion Institute, Haifa, Israel.
MMJ PhytoTech Ltd (ASX:MMJ) Update on Shareholding in Harvest One (CVE:HVST)
MMJ PhytoTech Limited (ASX:MMJ) notes the attached press release by Harvest One Cannabis Inc. (CVE:HVST) confirming that Harvest One intends to mandatorily convert certain of its convertible debentures into common stock on or about 28 March 2018. Post conversion, MMJ's current shareholding of 53,333,333 common shares in Harvest One will be 34.5% of the total outstanding shares.
Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report
Anatara Lifesciences (ASX:ANR) today released its Appendix 4D financial report for the half year ending 31st December 2017.
MMJ PhytoTech Ltd (ASX:MMJ) New CEO
MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce the appointment of Jason Conroy as Chief Executive Officer of MMJ effective from 26 February 2018.
MMJ PhytoTech Ltd (ASX:MMJ) Harvest One (CVE:HVST) Operational Update
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), of which MMJ holds 53,333,333 shares, has released an operational update on its wholly-owned horticultural subsidiary United Greeneries Ltd.
◂Previous Page
Drugs & OTC Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
- Basin Energy Ltd (ASX:BSN) Completes Phase One Drilling and Expands Sybella-Barkly
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
- BPH Energy Limited (ASX:BPH) Chair's Address to Shareholders
Social Media
